Vistin Pharma

Historical price data

Vistin Pharma is a publicly traded, pure-play manufacturer of Metformin API, leveraging over 50 years of production heritage from its Norwegian facilities. The company has established itself as a reliable, high-quality supplier to a diverse global client base, including big pharma and generics manufacturers, with its products sold in over 100 countries. Its strategic focus is on doubling its production capacity to over 7,000 MT/year to capture a larger share of the growing metformin market while emphasizing sustainable operations and maintaining its reputation for a nitrosamine-free product. Vistin's vision is to balance business growth with a commitment to having no negative impact on the environment, people, and local communities.

Specialized, cGMP manufacturing of Metformin Hydrochloride API and Direct Compressible (DC) granules, with a focus on high-purity synthesis and nitrosamine-free production processes.

Vistin competes primarily with large-scale, low-cost Metformin API manufacturers in China and India. Its differentiation is based on being a European supplier with high regulatory standards (FDA-inspected), a nitrosamine-free product, supply chain reliability, and a strong ESG profile, allowing it to compete on quality and security rather than price alone.